The
Partnering Agreements with Abbvie 2005-2013 report provides an in-depth insight
into the partnering interests and activities of one of the worlds leading
biopharma companies.
To Read the Complete Report with TOC
Visit:
http://www.marketresearchreports.biz/analysis-details/abbvie-partnering-2005-2013
This
report provides all the information you require to better understand Abbvie and
its partnering interests and activities over the past seven years.
On
demand company reports are prepared upon purchase to ensure inclusion of the
most up to date deal and company data.
The
report will be delivered in PDF format within 3 working days of receipt of
order. If print or CD-Rom version purchased, the report will be sent by courier
using express service.
This
report provides all the information you require to better understand Abbvie and
its partnering interests and activities over the past seven years.
One
of the key aspects of partnering is finding those companies that are potential
partners for the development and commercialization of the next generation of
therapies as developed by innovative biopharma R&D companies. A lot of
resources are spent on finding partners, identifying their interests and making
contact to initiate discussions.
Using
this report, dealmakers will effectively and efficiently target their
partnering activities to deliver the company’s business development objectives.
The
initial chapters of this report provide an orientation of bigpharma’s
dealmaking and business activities.
Chapter
1
provides an introduction to the report, whilst
Chapter
2
lists the top 50 leading biopharma companies based on 2010 pharmaceutical
revenues and their respective partnering activity.
Chapter
3
provides an overview of the leading partnering and M&A 2005 to present date
based on headline value.
Chapter
4
provides details on how to approach bigpharma companies with partnering
opportunities whilst
To Buy The Copy of This Report Visit: http://www.marketresearchreports.biz/analysis/173939
Chapter
5
lists forthcoming partnering events and conferences where bigpharma companies
will be present to discuss opportunities face to face.
The
main body of the report is provided in chapter 6. A profile of the
company provides everything required to assess the suitability of a company as
a prospective partner. This includes a company overview, partnering interests,
partnering activity according to deal type, industry sector, phase of
development, and therapy area. The profile also includes in-depth contact
information for individuals within the business development function.
The
deals are listed by deal type, stage of development and therapy focus, allowing
easy access to deals and alliances of interest. Every deal record links to an
online, live version of the deal record at the Current Agreements deals and
alliances database. Where available, deal records also include the contract
document as disclosed at the SEC.
One
of the key aspects of partnering is conducting due diligence on a partner to
determine under what terms a prospective partner agrees to a partnering
relationship.
Contact
M/s
Sheela
90
Sate Street, Suite 700
Albany,
NY 12207
USA
– Canada Toll Free: 866-997-4948
No comments:
Post a Comment